Cite

HARVARD Citation

    Ader, F. et al. (2022). Final results of the DisCoVeRy trial of remdesivir for patients admitted to hospital with COVID-19. Lancet infectious diseases. 22 (6), pp. 764-765. [Online]. 
  
Back to record